| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(94)70139-3 |
| P8608 | Fatcat ID | release_wsexsesbszdsfcdsvkkyrfsa5q |
| P698 | PubMed publication ID | 8021762 |
| P50 | author | Eric A F Simões | Q109845655 |
| P2093 | author name string | Johnson G | |
| Hall CB | |||
| Rodriguez WJ | |||
| Ryan ME | |||
| Groothuis JR | |||
| Arrobio J | |||
| Welliver R | |||
| Stutman H | |||
| Van Dyke R | |||
| P2860 | cites work | Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults | Q30451294 |
| Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84. | Q35570322 | ||
| Children hospitalized with influenza B infection | Q40796438 | ||
| Antiviral chemotherapy and chemoprophylaxis | Q41387891 | ||
| Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study | Q44603480 | ||
| Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection | Q45830739 | ||
| A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection | Q45854326 | ||
| Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. | Q50571779 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| ribavirin | Q421862 | ||
| multicenter clinical trial | Q6934595 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 129-135 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial | |
| P478 | volume | 125 |
| Q38926249 | Anti-Influenza Treatment: Drugs Currently Used and Under Development |
| Q39118405 | Antiviral Treatments |
| Q33950804 | Community respiratory virus infections in immunocompromised patients with cancer |
| Q24656164 | Current and future antiviral therapy of severe seasonal and avian influenza |
| Q37997822 | Identifying targets in the hunt for effective respiratory syncytial virus interventions |
| Q37857854 | Influenza pharmacotherapy: present situation, strategies and hopes |
| Q26822988 | Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead |
| Q37599884 | Motavizumab for the prevention of respiratory syncytial virus infection in infants |
| Q34164493 | New treatments for viral respiratory tract infections--opportunities and problems |
| Q35077260 | Nipah virus--a potential agent of bioterrorism? |
| Q30360609 | Pandemic flu. Clinical management of patients with an influenza-like illness during an influenza pandemic. |
| Q30359034 | Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the De |
| Q30305790 | Prevention and treatment of influenza in immunocompromised patients |
| Q41676840 | Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery |
| Q35566601 | Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years |
| Q40531597 | Resistance to antivirals |
| Q39178651 | Ribavirin attenuates the respiratory immune responses to influenza viral infection in mice |
| Q28235257 | Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis |
| Q48585293 | Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America |
| Q52340137 | South African medicinal plant extracts active against influenza A virus. |
| Q73497825 | Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies |
| Q92000536 | The Impact of RSV-Associated Respiratory Disease on Children in Asia |
| Q38367554 | The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals |
| Q36790658 | The threat of avian influenza A (H5N1). Part III: Antiviral therapy. |
| Q50585728 | Treatment of acute Nipah encephalitis with ribavirin. |
| Q54138583 | Zanamivir. |
| Q30327955 | Zanamivir: a rational approach to influenza B. |
Search more.